eISSN : 1525-1438
Frequency : 2 Issues per year
For Authors - International Journal of Trophoblastic Diseases

For Authors

Author Guidelines

Manuscript preparation

To hasten the review process, please format the manuscript in ways as follows:
Prepare your manuscript as a single MS Word document with 2.5 cm margins on A4 pages. The file should include the complete text, references, tables and figures. Manuscripts should be written in English and make sure all the characters in the text, tables, figure legends, footnotes and references are in Times New Roman typeface and 12 pt size. Type your manuscript single spaced and full justification. Beginning with the title page, please use the automatic page numbering function to number the pages. Use tab stops or other commands for indents, not the space bar.
All manuscripts must include the following section headings; ‘Title’, ‘Abstract’, a statement of the work's purpose in 'Introduction', followed by a brief description of the study's design in 'Materials and Methods' and a clear declaration of the 'Results', a concise presentation of the conclusions 'Discussion', 'Acknowledgments' (if any) and finally, ‘References’ have to be given.

Title Page

The first page as a title page should include a concise and informative title for the article accompanied by a short title to used as running head, full names and affiliations of all authors and standard mailing plus e-mail addresses, telephone and fax numbers of the corresponding author.


Following the title page, a structered abstract of the entire article should be outlined in subsections as follows; Objective, Materials and Methods, Results and Conclusions. The abstract should not contain any abbreviations and should not exceed 250 words for regular articles and 150 words for case reports. For review articles, the abstract should be separated into 2 to 4 paragraphs including an introductory viewpoint, information and discussion around the main theme and final considerations, without specifically named subheadings.


3 to 6 keywords have to be used for indexing purposes. The keywords may be placed under the abstract and in Medical Subject Headings (MeSH) terms should be used.


State concisely the purpose and rationale for the study and cite only the most pertinent references as background.

Material and Methods

Describe the plan, the patients, experimental animals, material and controls, the methods and procedures utilized, and the statistical methods employed. In addition to the normal peer review procedure, all randomized controlled trials (RCTs) submitted to the journal are sent to professional medical statisticians for reviewing. Address “Institutional Review Board” issues as stated above. State the generic names of the drugs with the name and country of the manufactures.


Present the detailed findings supported with statistical methods. Figures and tables should supplement, not duplicate the text; presentation of data in either one or the other will suffice. Emphasize only your important observations; do not compare your observations with those of others. Such comparisons and comments are reserved for the discussion section.


State the importance and significance of your findings but do not repeat the details given in the Results section. Limit your opinions to those strictly indicated by the facts in your report. Compare your finding with those of others. No new data are to be presented in this section. The discussion should end with one concluding paragraph.


Maximum 30 references should be cited, numbered in brackets in the text and listed in the References section in the order they appear in the text. All authors names of the cited paper have to listed in references. Journal titles should conform to the abbreviations used in “Cumulated Index Medicus” as shown below:

Journal article:
1. Ngan HY, Kohorn EI, Cole LA, Kurman RJ, Kim SJ, Lurain JR, Seckl MJ, Sasaki S, Soper JT. Trophoblastic disease. Int J Gynaecol Obstet. 2012 Oct;119 Suppl 2:S130-6.

E-journal article:
1. Cole LA. New discoveries on the biology and detection of human chorionic gonadotropin. Reproductive Biology and Endocrinology 2009, 7:8. http://www.rbej.com/content/7/1/8

Book chapter:
1. Fisher RA, Sebire NJ. Gestational trophoblastic disease. In: Moffett A, Locke C and McLaren A (Eds.), Biology and Pathology of Trophoblast, Cambridge University Press, 2006, pp 74-110.

1. Slim R. How many patients have mutations in NLRP7? 2013. http://slimlab.mcgill.ca/infopatient.htm#qe9

Tables and Figures

Tables and figures should work under “Windows”. Color figures or gray-scale images must be at least 300 dpi. Figures must be submitted in the form of tiff, jpg or jpeg files. Number tables and figures consecutively in the order of their first citation in the text. They should be numbered in Arabic numerals. Each table must have a title indicating the purpose or content of each table. Be sure that each table is cited in the text. Do not use internal horizontal and vertical rules. Place explanatory matter in footnotes, not in the heading. Explain in footnotes all abbreviations used in each table. Each figure must have an accompanying legend defining abbreviations or symbols found in the figure.


Units of measurement should be in Systéme International (SI) units. Abbreviations except hcg-human chorionic gonadotropin should be avoided in the title. Abbreviations should be defined at first mention and used consistently thereafter. If the article includes an excessive number of abbreviations, the authors should additionally add a list for all abbreviations used. Generic names of drugs and chemicals are preferred; if trade names are used, the generic name should be given at least at first mention.


Acknowledgments of people, grants, funds, etc should be placed in a separate section before the reference list. The names of funding organizations should be written in full.

Ethical Standards

Manuscripts submitted for publication must contain a statement to the effect that all studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted. Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owners and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to be originated from the authors. The author will be held responsible for false statements or failure to fulfill the above-mentioned requirements.

Conflicts of Interest

Authors must indicate whether or not they have a financial relationship with the organization that sponsored the research. This note should be added in a separate section before the reference list. If no conflict exists, authors should state: The authors declare that they have no conflict of interest.


The authors transfers the copyright to their article to the IJTD effective if and when the article is accepted for publication. The copyright covers the exclusive and unlimited rights to reproduce and distribute the article in any form of reproduction (printing, electronic media or any other form); it also covers translation rights for all languages and countries.

Manuscript submission

All manuscripts should be submitted online via the IJTD online manuscript submission and review system after logging on to the website www.ijtd.org. Please attach the cover letter with Author Agreement Form and declared that the submitted manuscript should not have been previously published in any form and must not be currently under synchronous consideration for publication elsewhere, that its publication has been approved by all co-authors as well as by the responsible author. An author declaration form should be signed by all authors. For the declaration of these details the publishers Author Agreement Form have to be downloaded, filled out and then submitted together with the manuscript. The publisher will not be held legally responsible if there should be any claims for compensation. A Copyright Transfer Agreement Form should be signed after the acceptance for publication.

Review Process

All manuscripts will be evaluated by the scientific board for their scientific contribution, originality and content. Manuscripts not adhering to journal guidelines will be returned to authors without scientific evaluation. Submitted manuscripts adhering to journal guidelines are reviewed by the Scientific Editor-in-Chief or Executive Editor, who will assign them to reviewers. The Editorial Board prepares a decision letter according to the comments of the reviewers, which is sent to the corresponding author. All non-reviewed manuscripts are sent back within 2 weeks and decisions letters of manuscripts are sent within 4 weeks. The journal retains the right to make appropriate changes on the grammar and language of the manuscript.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
1. The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
2. The submission file is in OpenOffice, Microsoft Word, RTF, or WordPerfect document file format.
3. Where available, URLs for the references have been provided.
4. The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
5. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in For Authors.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
  • Author Agreement Form
  • Copyright Transfer Agreement Form
  • Submit your paper
  • Track your paper
Trofoblastik Hastalıklar Derneği

LookUs & Online Makale